| Business Summary | | A-FEM
Medical
Corporation
is
a
development
stage
medical
technology
company
with
multiple
product
platforms
targeting
women's
health
needs.
A-FEM
has
developed
three
proprietary
technology
platforms:
one
based
on
its
inSync
miniform
interlabial
pad,
another
based
on
its
RapidoSense
diagnostic
tests,
and
the
third
based
on
its
PadKit
Sample
Collection
System.
A-FEM
currently
markets
the
inSync
miniform
as
an
alternative
to
tampons,
pads
and
liners
for
light
flow,
or
in
combination
for
heavier
flow
protection.
The
PadKit,
currently
in
clinical
trials,
utilizes
a
miniform
as
a
non-invasive
sample
collection
method
for
use
in
testing
for
certain
cancers
and
sexually
transmitted
and
infectious
diseases.
A-FEM
has
also
entered
into
several
joint
relationships
to
develop
point-of-care
diagnostic
products
that
use
its
proprietary
RapidoSense
technology. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | A-FEM
Medical
Corporation
is
a
medical
technology
company
targeting
unmet
needs
in
women's
health.
The
Company's
three
proprietary
platforms
are
the
miniform,
the
PadKit(TM)
and
Rapid-Sense(TM).
For
the
six
months
ended
6/30/01,
net
sales
fell
57%
to
$8
thousand.
Net
loss
fell
34%
to
$575
thousand.
Revenues
reflect
decreased
levels
of
promotional
support
for
the
inSync
miniform
platform.
Lower
loss
reflects
reductions
in
professional
fees
and
travel
costs. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| James Reinmuth, Ph.D., 60 Chairman | $30K | Steven Frankel, 58 CEO,
Pres | 240K | William Fleming, Ph.D., 54 Vice
Chairman-Diagnostics, Sec. | 115K | James Wilson, 51 Treasurer,
Director of Bus. Devel. | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|